Head of Investor Relations
Solventum Corp (SOLV)Head of Investor Relations
Cardinal Health Inc (CAH)Equibles does not estimate personal net worth.
Get an email with a short summary when Solventum Corp publishes a filing, an earnings call transcript or a press release.
Get SOLV alertsKevin Moran is recorded as Head of Investor Relations at Solventum Corp (SOLV), COO at AlTi Global, Inc. (ALTI) and Head of Investor Relations at Cardinal Health Inc (CAH). The newest filing on record that lists Kevin Moran as COO at AlTi Global, Inc. (ALTI) is dated April 30, 2026. AlTi Global, Inc. reported in an 8-K filed July 2, 2026 that Kevin Moran was appointed President and Chief Operating Officer, effective July 1, 2026. AlTi Global, Inc. reported in an 8-K filed March 22, 2024 that Kevin Moran was appointed President, effective March 22, 2024. AlTi Global, Inc. reported in an 8-K filed January 9, 2023 that Kevin Moran was appointed Chief Operating Officer. The proxy statement of AlTi Global, Inc. reports total compensation of $4,572,569 for Kevin Moran in fiscal 2025, including a base salary of $450,000. Disclosed compensation is on record for 3 fiscal years. Kevin Moran has spoken on 17 earnings calls across 3 companies, most recently for AlTi Global, Inc. on August 10, 2026. Those appearances were for Cardinal Health Inc (CAH), AlTi Global, Inc. (ALTI) and Solventum Corp (SOLV). Cardinal Health Inc is classified in the Medical Distribution industry within the Healthcare sector. AlTi Global, Inc. is classified in the Asset Management industry within the Financial Services sector. Other leadership on record at Cardinal Health Inc includes Debbie Weitzman (CEO), Deborah L. Weitzman (CEO), Jason Hollar (CEO) and 7 others.
“WHEREAS, the Company has appointed Executive to serve as President and Chief Operating Officer, and the parties desire to update the Agreement to reflect Executive's new title and revised compensation”
“On March 22, 2024, AlTi Global, Inc. (the "Company") announced that the Company promoted Kevin Moran to the role of President, adding to his current role of Chief Operating Officer of the Company, effective immediately.”
“Yes, the zero-based budgeting, I think as we talked about on prior calls, is the budgeting methodology that we're using at ALTI. So we've now used it, I think this is the second year that we've used it.”
“Wilma, I've spoken to you in the past on some of these calls. So as I think you know, myself, Nancy, Mike Tiedemann, like the management team here at the firm has been together for a very long time.”
“Today, we will discuss Solventum's third quarter fiscal 2024 results, along with an update to our 2024 outlook. Just after market close today, a press release was issued with our earnings results and updated outlook.”
“Today, we will discuss Cardinal Health’s fourth quarter and fiscal year end 2023 results, along with our outlook for fiscal year '24.”
“Today we will discuss Cardinal Health's third quarter fiscal 2023 results, along with updates to our full year outlook.”
SEC 8-K
2024-03-22–present
Start not stated–present
Last confirmed April 30, 2026
Medical Distribution · Healthcare
Head of Investor Relations
ALTI
Asset Management · Financial Services
COO
2024-03-22–present
SOLV
Medical Instruments & Supplies · Healthcare
Head of Investor Relations
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AlTi Global, Inc. (ALTI) | President and Chief Operating Officer | $450,000 | $4,572,569 |
| 2024 | AlTi Global, Inc. (ALTI) | President and Chief Operating Officer | $400,000 | $2,792,516 |
| 2022 | AlTi Global, Inc. (ALTI) | Chief Operating Officer | $375,000 | $1,000,000 |
